Latest News
Hemab Therapeutics Holdings, Inc.
- Hemab Therapeutics Holdings, Inc.'s (NASDAQ:COAG) Lock-Up Period Will Expire on October 28th
- Hemab Therapeutics (NASDAQ:COAG) Shares Gap Up - Time to Buy?
- Hemab Therapeutics (NASDAQ:COAG) Stock Rated Overweight in New Coverage at JPMorgan Chase & Co.
- JPMorgan initiates Hemab Therapeutics stock with overweight rating
- Hemab Therapeutics (NASDAQ:COAG) Stock Price Up 8.4% - Here's What Happened
- Hemab Therapeutics (NASDAQ:COAG) Now Covered by Analysts at Rodman & Renshaw
- Hemab Therapeutics (NASDAQ:COAG) Shares Up 6% - Time to Buy?
- Hemab Therapeutics (NASDAQ:COAG) Stock Price Down 7.5% - What's Next?
- Hemab Therapeutics (NASDAQ:COAG) Shares Gap Down - Here's What Happened
- Hemab Therapeutics: The Market Is Pricing One Rung Of A Four-Rung Ladder (NASDAQ:COAG)
- Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
Headlines from the last 30 days, linking to the original publishers. See all market news →